Spravato (esketamine) has possible interactions with alcohol, some other drugs, and certain supplements. Examples include Adderall and benzodiazepines such as clonazepam (Klonopin). Talk with your ...

Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

Tesla and SpaceX CEO Elon Musk clarified that he uses only "a small amount once every other week or something like that" ...

Both drugs were given on top of standard antidepressants to patients wo had failed a least two earlier treatments. Spravato has been approved since 2019 for TRD, with its label extended the ...

The Institute for Clinical and Economic Review (ICER) has published its final report on Spravato (esketamine) and says the drug would need to be between 25% and 52% cheaper to meet its value ...

Johnson & Johnson will stop late-stage studies of its experimental drug to treat major depressive disorder due to a lack of sufficient efficacy, the drug and medical device maker said on Thursday.

In terms of the newest collaboration, the health care professionals said they decided that having all the services under one ...

SPRAVATO has been increasing in sales for the ... to a patient that's suffering from schizophrenia. So this is a daily drug. It's an interesting compound as just a quick detour from what we ...

However, it may cover Spravato, which contains esketamine. This is an FDA-approved drug that derives from ketamine and can help manage treatment-resistant depression. Despite not yet having FDA ...

Intake assessments, Spravato, TMS therapy, integration therapy and medication management are eligible for insurance coverage depending on your plan and location. We also offer interest-free in ...